Benzinga | Jun 29, 2021 06:36AM EDT

SVB Leerink Maintains Outperform on Bio-Techne, Raises Price Target to $480

SVB Leerink analyst Puneet Souda maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target from $450 to $480.